In a Jan. 2 posting on the Coalition for Healthcare Communication Web site regarding the FDA’s recently released draft guidance on how industry should respond to unsolicited requests for off-label information, Coalition Executive Editor John Kamp said that although the guidance is “clear and authoritative, the FDA missed a great opportunity to ensure that doctors and patients have even better access to life-saving data.” The posting includes a summary of the draft guidance and additional comments by Kamp. Read more.

Full Story:

Related Summaries